TRA.VN Traphaco JSC

Healthcare Drug Manufacturers - Specialty & Generic Vietnam Stocks
Add to portfolio Ask AI about TRA.VN
35,050 VND
Close of Oct 30, 2026
29,201 38,950
Market cap
VND 2.94T
P/E
12.1x
P/B
1.92x
ROE
16.0%
Dividend yield
5.68%
Fundamental score
2.3/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is TRA.VN undervalued?

Graham number
Price35,050
Graham value34,511
Premium1.6%

TRA.VN trades 1.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Traphaco JSC fundamental analysis

12 of 22 checks passed

ROE 1/2

Moderate return on equity (16.0%), between 10% and 20%.

ROA 0/1

Return on assets (10.1%) is below the industry median (11.7%).

Profit Consistency 2/2

Profitable for 7 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 1/1

Last year's EPS growth (4.5%) is above the 5-year average (-8.6% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (4.5%) is below the industry median (5.0%).

Revenue Growth 1/2

Revenue grew 3.5% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

EBIT is 37.5x against interest expense, well covered.

PE vs Market 0/1

PE (12.2x) is above the market median (11.2x).

PE vs Industry 1/1

PE (12.2x) is below the industry median (13.1x).

PBV 1/1

Price to book (1.9x) is below the industry median (2.2x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 23.8, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (5.7%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 66.9%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Traphaco JSC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Traphaco JSC

Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases, nutritional food products, and medicines derived from medicinal herbs; trading …

Full company profile